A groundbreaking AI model is set to transform molecular chemistry by uncovering previously unknown molecules. With its ability to analyze complex data, DreaMS could lead to significant advancements in pharmaceuticals and our understanding of life itself.

In a groundbreaking development poised to revolutionize the field of molecular chemistry, a new machine learning model known as DreaMS is making waves by significantly accelerating the analysis of previously unknown molecules.
Published in the prestigious journal Nature Biotechnology, this innovation emerges from the collaborative efforts of a distinguished team, including the Neuron Prize-winning Dr. Tomás Pluskal, his student Roman Bushuiev, and esteemed colleagues from the Czech Institute of Informatics, Robotics, and Cybernetics at the Czech Technical University, namely Dr. Josef Sivic and Anton Bushuiev.
The vast expanse of nature is brimming with chemical substances yet to be discovered.
It is widely believed that most natural molecules remain elusive, and identifying them could pave the way for groundbreaking advancements in pharmaceuticals, eco-friendly pesticides, a deeper understanding of biological processes, and even advanced research into the possibilities of life beyond our planet.
Every substance boasts a unique pattern, akin to a human fingerprint, known as a mass spectrum, which can be captured using a method called mass spectrometry.
However, while this approach generates vast quantities of data, deciphering it to unveil exact molecular structures is a daunting task.
The resulting datasets often appear as lengthy tables of numbers, devoid of apparent meaning.
Enter the realm of artificial intelligence.
By drawing parallels to large language models like ChatGPT, which learn to comprehend language without prior knowledge of word meanings, the DreaMS model attempts to interpret mass spectra without pre-existing chemical structure knowledge.
“Just as ChatGPT can infer word meanings and their connections from massive text volumes, the DreaMS neural network, through self-supervised learning, learns to recognize hidden molecular structures in spectra.
It is based on data from millions of examples,” explains Dr. Sivic.
The DreaMS model was trained on tens of millions of spectra from diverse organisms and environments, including plants, microbes, foods, tissues, and soil samples.
This extensive training allows it to uncover hidden similarities between spectra that, at first glance, seem unrelated.
According to Dr. Pluskal, the result is an interconnected network that facilitates navigation through the vast chemical data landscape.
This network, envisioned as a “network of mass spectra,” has been aptly named the Atlas DreaMS.
Each spectrum is like a web page linked to others, enabling users to explore discovered connections and pose new questions, such as the chemical commonalities between pesticides, foods, and human skin.
Remarkably, DreaMS has unearthed unexpected chemical similarities among these elements, raising the hypothesis that certain pesticides may be linked to autoimmune diseases like psoriasis.
Beyond connecting spectra from different studies, DreaMS can also be employed for various practical tasks, such as estimating the number of specific fragments a molecule contains or determining whether it includes specific chemical elements.
A particularly intriguing discovery was the model’s ability to detect fluorine.
“We were especially surprised that the model learned to detect fluorine,” shares Roman Bushuiev.
Fluorine is present in approximately one-third of all drugs and agrochemicals, yet previously, it couldn’t be reliably detected from mass spectra.
After pre-training DreaMS with millions of spectra, it was fine-tuned with thousands of examples of molecules containing fluorine, and suddenly, it worked.
Now, the researchers are focused on the next ambitious step: teaching the model to predict complete molecular structures.
If successful, this advancement could radically transform our understanding of chemical diversity, not only on Earth but across the universe, the authors assert.
This development marks a pivotal moment in the integration of artificial intelligence with chemical discovery.
By bridging the gap between vast data and tangible insights, DreaMS is not merely a tool but a potential catalyst for innovation across multiple fields.
As we stand on the brink of these new discoveries, one can’t help but wonder about the untapped potential residing in the molecules around us, waiting for a digital key to unlock their secrets.